National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 60219-60220 [2023-18836]
Download as PDF
Federal Register / Vol. 88, No. 168 / Thursday, August 31, 2023 / Notices
60219
TABLE 1—RECIPIENTS AND AWARD AMOUNTS
Grant No.
Award recipient name
City, state
Award
amount
UF5MC32750 ..........................
National Institute for Children’s Health Quality ........................
Boston, MA .............................
$1,900,000
Justification: HRSA will provide
supplemental award funds to the
current SHSPP recipient in fiscal year
2023 to provide new and continued
support to Healthy Start grant
recipients. The current recipient of the
SHSPP is best positioned to address the
objectives that to be supported by the
supplemental funds, including
supporting data collection and
evaluation and implementing applicable
Executive Orders.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Carole Johnson,
Administrator.
ACTION:
[FR Doc. 2023–18798 Filed 8–30–23; 8:45 am]
SUMMARY:
Health Resources and Services
Administration
HRSA-Initiated Supplemental Funding
to the Supporting Maternal Health
Innovation Program
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
AGENCY:
Notice of supplemental award.
HRSA is providing
supplemental funds not to exceed
$1,500,000 to the Supporting Maternal
Health Innovation Program, also
referred to as the Maternal Health
Learning and Innovation Center
(MHLIC), in fiscal year (FY) 2023 to
provide support and capacity building
to HRSA’s new maternal health award
recipients under the State Maternal
BILLING CODE 4165–15–P
Health Innovation (MHI) Program
(HRSA–23–108).
FOR FURTHER INFORMATION CONTACT:
Kimberly Sherman, Chief, Maternal and
Women’s Health Branch, Division of
Healthy Start and Perinatal Services,
Maternal and Child Health Bureau,
HRSA, at ksherman@hrsa.gov or (301)
443–1702.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award: One
award to the University of North
Carolina at Chapel Hill, the current
recipient under the Supporting Maternal
Health Innovation Program, now known
as MHLIC, as listed in Table 1.
Amount of Non-Competitive Award:
Up to $1,500,000.
Project Period: September 30, 2019, to
September 29, 2024.
CFDA Number: 93.110.
Award Instrument: Supplement.
Authority: 42 U.S.C. 701(a)(2) (title V,
section 501(a)(2) of the Social Security
Act).
ddrumheller on DSK120RN23PROD with NOTICES1
TABLE 1—SUPPORTING MHI PROGRAM AWARD RECIPIENT (2019–2024)
Grant No.
Grantee organization
City, state
Award
amount
U7CMC33636
University of North Carolina at Chapel Hill .....................................................................................
Raleigh, NC ...
$1,500,000
Justification: The Consolidated
Appropriations Act, 2023 (Pub. L. 117–
328) included additional Special
Projects of Regional and National
Significance funding. The Explanatory
Statement accompanying the
Consolidated Appropriations Act
specified a $26 million increase for the
State MHI Program to establish new
cooperative agreements in FY 2023 with
up to 23 new states. MHLIC provides
support and capacity building to
HRSA’s maternal health award
recipients. Supplemental funds to
MHLIC will be used to provide support
and capacity building to the new cohort
of FY 2023 State MHI award recipients.
The requested activities are within
scope of the Supporting Maternal Health
Innovation Program.
Carole Johnson,
Administrator.
[FR Doc. 2023–18799 Filed 8–30–23; 8:45 am]
BILLING CODE 4165–15–P
VerDate Sep<11>2014
18:04 Aug 30, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK SEP High
Risk Multi-Center Clinical Study Cooperative
Agreement U01.
Date: September 28, 2023.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Cheryl Nordstrom, Ph.D.,
MPH, Scientific Review Officer, NIDDK/
Scientific Review Branch, National Institutes
of Health, 6707 Democracy Blvd., Room
7013, Bethesda, MD 20892, 301–402–6711,
cheryl.nordstrom@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\31AUN1.SGM
31AUN1
60220
Federal Register / Vol. 88, No. 168 / Thursday, August 31, 2023 / Notices
Dated: August 28, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–18836 Filed 8–30–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Lung Cellular, Molecular, and
Immunobiology Study Section.
Date: September 26–27, 2023.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Blvd., Gaithersburg, MD 20878.
Contact Person: George M Barnas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, 301–435–
0696, barnasg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–22–
079: High-End Instrumentation (HEI) Grant
Program.
Date: September 26, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Krystyna H Szymczyk,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–4198, szymczykk@
csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Health Services: Quality and Effectiveness
Study Section.
Date: September 27–28, 2023.
Time: 9:00 a.m. to 7:00 p.m.
VerDate Sep<11>2014
18:04 Aug 30, 2023
Jkt 259001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Angela D Thrasher, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J,
Bethesda, MD 20892, (301) 480–6894,
thrasherad@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Pathophysiological Basis of Mental
Disorders and Addictions Study Section.
Date: September 27–28, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Boris P. Sokolov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217A,
MSC 7846, Bethesda, MD 20892, 301–408–
9115, bsokolov@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Developmental Brain Disorders Study
Section.
Date: September 27–29, 2023.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pat Manos, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, (301) 408–
9866, manospa@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Maximizing Investigators’ Research Award—
F Study Section.
Date: September 27–28, 2023.
Time: 10:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian Paul Chadwick,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–3586, chadwickbp@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 28, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–18837 Filed 8–30–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the Council of Councils,
September 07, 2023, Partially Closed
Meeting that was published in the
Federal Register on August 08, 2023, 88
FR 53504.
The publication is being amended to
change the open session end time ‘‘3:15
p.m.’’ to ‘‘3:00 p.m.’’. In the amended
portion of the notice, the open session
end time of the Council of Councils
meeting was listed in error. The meeting
is partially closed to the public.
Dated: August 25, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–18880 Filed 8–30–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of K99/R00 Applications.
Date: October 24–25, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Tracy Koretsky, Ph.D.,
Scientific Review Officer, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, MSC
6200, Room 3AN12F, Bethesda, Maryland
E:\FR\FM\31AUN1.SGM
31AUN1
Agencies
[Federal Register Volume 88, Number 168 (Thursday, August 31, 2023)]
[Notices]
[Pages 60219-60220]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18836]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK SEP High Risk
Multi-Center Clinical Study Cooperative Agreement U01.
Date: September 28, 2023.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, NIDDK, Democracy II, Suite
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Cheryl Nordstrom, Ph.D., MPH, Scientific Review
Officer, NIDDK/Scientific Review Branch, National Institutes of
Health, 6707 Democracy Blvd., Room 7013, Bethesda, MD 20892, 301-
402-6711, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
[[Page 60220]]
Dated: August 28, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-18836 Filed 8-30-23; 8:45 am]
BILLING CODE 4140-01-P